Found: 21
Select item for more details and to access through your institution.
Prediction of the potential mechanism of compound gingerol against liver cancer based on network pharmacology and experimental verification.
- Published in:
- Journal of Pharmacy & Pharmacology, 2022, v. 74, n. 6, p. 869, doi. 10.1093/jpp/rgac002
- By:
- Publication type:
- Article
Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 3, p. 1016, doi. 10.3390/pharmaceutics15031016
- By:
- Publication type:
- Article
ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 1, p. 89, doi. 10.3390/pharmaceutics14010089
- By:
- Publication type:
- Article
U.S. patient preferences for long-acting HIV treatment: a discrete choice experiment.
- Published in:
- Journal of the International AIDS Society, 2023, v. 26, p. 5, doi. 10.1002/jia2.26099
- By:
- Publication type:
- Article
U.S. patient preferences for long‐acting HIV treatment: a discrete choice experiment.
- Published in:
- Journal of the International AIDS Society, 2023, v. 26, p. 1, doi. 10.1002/jia2.26099
- By:
- Publication type:
- Article
The systematic development of attributes and levels for a discrete choice experiment of HIV patient preferences for long-acting antiretroviral therapies in the United States.
- Published in:
- AIDS Research & Therapy, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12981-022-00435-6
- By:
- Publication type:
- Article
Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies.
- Published in:
- PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0300723
- By:
- Publication type:
- Article
Correction to: Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products.
- Published in:
- AAPS Journal, 2020, v. 22, n. 5, p. N.PAG, doi. 10.1208/s12248-020-00470-z
- By:
- Publication type:
- Article
pH-Responsive Artemisinin Derivatives and Lipid Nanoparticle Formulations Inhibit Growth of Breast Cancer Cells <i>In Vitro</i> and Induce Down-Regulation of HER Family Members.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0059086
- By:
- Publication type:
- Article
Novel Gd Nanoparticles Enhance Vascular Contrast for High-Resolution Magnetic Resonance Imaging.
- Published in:
- PLoS ONE, 2010, v. 5, n. 9, p. 1, doi. 10.1371/journal.pone.0013082
- By:
- Publication type:
- Article
Human Liver Cytochrome P450 2D6 Genotype, Full-length Messenger Ribonucleic Acid, and Activity Assessed with a Novel Cytochrome P450 2D6 Substrate<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 4, p. 282, doi. 10.1016/j.clpt.2003.12.003
- By:
- Publication type:
- Article
Drug Combination Nanoparticles Containing Gemcitabine and Paclitaxel Enable Orthotopic 4T1 Breast Tumor Regression.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2792, doi. 10.3390/cancers16162792
- By:
- Publication type:
- Article
Viral dissemination and immune activation modulate antiretroviral drug levels in lymph nodes of SIV-infected rhesus macaques.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1213455
- By:
- Publication type:
- Article
Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0228557
- By:
- Publication type:
- Article
MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents.
- Published in:
- 2009
- By:
- Publication type:
- journal article
MDR1 ( ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 183, doi. 10.1007/s00280-008-0906-4
- By:
- Publication type:
- Article
Pharmacogenetics of Intravenous and Oral Busulfan in Hematopoietic Cell Transplant Recipients.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 10, p. 1429, doi. 10.1177/0091270010382915
- By:
- Publication type:
- Article
Effects of Garlic on Cytochromes P450 2C9- and 3A4-Mediated Drug Metabolism in Human Hepatocytes.
- Published in:
- Scientia Pharmaceutica, 2010, v. 78, n. 3, p. 473, doi. 10.3797/scipharm.1002-11
- By:
- Publication type:
- Article
"Lighten This Burden of Ours": Acceptability and Preferences Regarding Injectable Antiretroviral Treatment Among Adults and Youth Living With HIV in Coastal Kenya.
- Published in:
- 2021
- By:
- Publication type:
- journal article
"Lighten This Burden of Ours": Acceptability and Preferences Regarding Injectable Antiretroviral Treatment Among Adults and Youth Living With HIV in Coastal Kenya.
- Published in:
- Journal of the International Association of Providers of AIDS Care, 2021, p. 1, doi. 10.1177/23259582211000517
- By:
- Publication type:
- Article